MIRA Pharmaceuticals (MIRA) Earnings Date & Reports
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MIRA is expected to report earnings to fall 23.08% to -10 cents per share on September 03
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.01
The last earnings report on May 28 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 140.28K shares outstanding, the current market capitalization sits at 16.26M.